Wed, Nov 26, 2014, 4:11 AM EST - U.S. Markets open in 5 hrs 19 mins


% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • frankfrazzano frankfrazzano Dec 10, 2013 11:48 AM Flag

    Any BETS that Larry Smith sold into IMUC/NWBO recent run and now owns CLDX?

    Celldex: Equity Offering Is A Positive For The Stock (CLDX, $25.88) 0 comments
    Dec 5, 2013 10:35 AM

    Celldex (CLDX) has just announced a financing in which the Company has issued 7.0 million shares and will receive net proceeds of $163 million. If the Green Shoe is exercised, as seems likely, shares issued and net proceeds would be 8.05 million and about $187 million, respectively.

    The Company had $136 million of cash as of the end of 3Q, 2013. On a pro forma basis, it has raised the cash position to $323 million. The recent operating cash burn has been $17.5 million per quarter so that at that rate the Company can fund 18.5 quarters of operations as opposed to 7.8 quarters pre-offering.

    The number of shares outstanding is increased from 81.0 to 89.1. At the recent price of $25.88 the market capitalization is now $2.3 billion. This removes the financing overhang for the Company, which was emerging as an issue, and this is a positive for the stock. I think that it is inappropriate to use the term fortress balance sheet for a company burning through $70 million a year. However, this is an exceptionally strong balance sheet for an emerging biotechnology company.

    I have an update on recent rindopepimut results as presented at SNO in the works and I will update my investment thinking in that report.

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.



    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
20.38-0.5500(-2.63%)Nov 25 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.